Research Funding
Description:
ATS/Pulmonary Hypertension Association Research Grant (2 grants available in this category).
Deadline:
Letter of Intent (LOI) Deadline: June 25, 2008 (check website for specific deadline in spring 2008)
More information on how to apply
This is a joint research award that will be co-funded by the ATS and the Pulmonary Hypertension Association, one of the ATS Public Advisory Roundtable members. Two research grants will be awarded to support novel studies of the diagnosis, pathogenesis, treatment or outcomes of pulmonary hypertension. Applicants may request up to $50,000/year for 2 years for salaries, supplies or a combination of these two. Applicants must meet the criteria listed below on this website. A primary goal of the ATS research program is to enable new faculty-level investigators to make the transition to careers as established investigators. Partnerships between junior and senior investigators are strongly encouraged, particularly for new investigators who are within 1 to 5 years of the completion of their training. Both US and non-US based investigators are encouraged to apply. One of the investigators must be an ATS member at the time of application, and the Principal Investigator must be an ATS member at the time that the grant is awarded. Indirect costs will not be paid to the sponsoring institution.
Namasivayam Ambalavanan, M.B.B.S., M.D.
University of Alabama at Birmingham
“Transforming Growth Factor-β and Effects of Hypoxia on the Newborn Lung”
Term: January 1, 2007 – December 31, 2008
Arlin Brice Blood, Ph.D.
Loma Linda University School of Medicine
“The Interaction of Nitric Oxide and Hemoglobin in Regulation of Pulmonary Vascular Tone”
Term: January 1, 2007 – December 31, 2008
Xinqi Wu, Ph.D.
Children’s Hospital Boston
“Hypoxic regulation of BMP signaling and the role of Id1 in the development of pulmonary hypertension”
Term: January 1, 2006 – December 31, 2007
Todd Bull, M.D.
University of Colorado
“The role of Kaposi’s sarcoma herpesvirus in the development of severe pulmonary hypertension”
Term: January 1, 2006 – December 31, 2007
